ArticleFrontiers in epidemiology2025
Estimation of the transition rates in the illness-death model for chronic diseases from aggregated current status data: a feasibility and simulation study.
Article in Frontiers in epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Estimation of the transition rates in the illness-death model for chronic diseases from aggregated current status data: a feasibility and simulation study.Frontiers in epidemiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recently, it has been shown that the transition rates of the illness-death model (IDM) for chronic conditions are related to the age-specific prevalence by a partial differential equation (PDE). Given mortality, the PDE could be used to estimate incidence rates from cross-sectional data. The aim of this article is to extend the IDM and introduce a novel method to estimate the age-specific incidence rate together with the two mortality rates from aggregated current status (ACS) data. By ACS data we mean counts of people in the four states of the extended IDM at different points in time. ACS data stem from epidemiological studies where only current disease status and vital status data need to be collected without following-up people (as, for example, in cohort studies). To demonstrate feasibility of the method, we use a simulation study from the context of diabetes in Germany. Two estimation methods are introduced, a least squares estimator and a maximum likelihood estimator. We find a good agreement between the estimates and the input parameters used to set up the simulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.